Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...